Serum growth differentiation factor-15 levels are associated with the severity of diabetic foot ulcer
- PMID: 36280643
- DOI: 10.1007/s42000-022-00408-4
Serum growth differentiation factor-15 levels are associated with the severity of diabetic foot ulcer
Abstract
Aims: To assess serum growth differentiation factor-15 (GDF-15) levels in patients with diabetic foot ulcer and to reveal whether any association exists between GDF-15 and the severity of diabetic foot ulcer.
Design: A cross-sectional study including three age- and sex-matched cohorts comprising 17 patients (7 F, mean age: 52 ± 7 years) with diabetic foot ulcer (DMf), 17 patients with type 2 diabetes (6 F, mean age: 51 ± 6 years) with no foot complication (DM), and 20 healthy controls (8 F, mean age: 50 ± 8 years) (C) was conducted.
Results: DMf had higher GDF-15 levels, followed by DM and C (GDF-15, median ± IQR (pg/mL), DMf: 1039 (884-1566), DM: 649 (375-1148), and C: 296 (212-534), p < 0.001). The severity of diabetic foot disease was positively associated with serum GDF-15 (GDF-15, median ± IQR (pg/mL), Wagner grade 1: 893 (698-1039), Wagner grade 3: 1705 (1348-2197), and Wagner grade 4: 3075 (1974-4176), p for trend = 0.006). In multivariate regression model, only Wagner grade (β = 0.55, 95% CI (87-753), p = 0.02) was found to be an independent factor affecting serum GDF-15 concentration.
Conclusions: Serum GDF-15 levels are high in patients with diabetic foot ulcer. The level is higher in more advanced lesions. GDF-15 measurement can have clinical utility in the management of diabetic foot ulcers.
Keywords: Complication; Diabetic foot; GDF-15; Type 2 diabetes mellitus; Wagner grade.
© 2022. The Author(s), under exclusive licence to Hellenic Endocrine Society.
References
-
- IDF Diabetes Atlas Tenth Edition, Belgium. International Diabetes Federation (2019) https://diabetesatlas.org/
-
- Armstrong DG, Boulton AJM, Bus SA (2017) Diabetic foot ulcers and their recurrence. N Engl J Med 376(24):2367–2375. https://doi.org/10.1056/NEJMra1615439 - DOI - PubMed
-
- Wischhusen J, Melero I, Fridman WH (2020) Growth/differentiation factor -15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol 11:951. https://doi.org/10.3389/fimmu.2020.00951 - DOI - PubMed - PMC
-
- Wollert KC, Kempf T, Wallentin L (2017) Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem 63(1):140–151. https://doi.org/10.1373/clinchem.2016.255174 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical